Towards nanomedicines: design protocols to assemble, visualize and test carbon nanotube probes for multi-modality biomedical imaging

Sofia I Pascu, Rory L Arrowsmith, S R Bayly, Simon Brayshaw, Zhiyuan Hu

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Nanomedicine is an interdisciplinary field, still in its infancy, where an accurate scientific assessment of potential risks and benefits is urgently needed, as is the engagement of end users and the public in this facet of the nanotechnology debate. There is increasing interest in improving our understanding of the interactions between nanomaterials and living systems, with regard to both the underlying chemistry and the physics of effects on the nanoscale. Ultimately, such knowledge promises new vistas for designing the ‘smart’ medicines of the future, of which targeted personalized drugs are the holy grail. Imaging and therapeutic components, including metallic radioisotopes, semiconductor quantum dots and magnetic materials, may be used to construct ‘nanocarriers’ (by encapsulation or conjugation) by rapid and simple (covalent and supramolecular) chemistry. The biomedical functions of the resulting materials are as yet largely unexplored. Encapsulation in nanocarriers could achieve delivery of the reagents (imaging and therapeutic drugs) to the sites of action in the body, while minimizing systemic toxicity and enzymatic degradation. These functional systems have the potential to become a general solution in drug delivery. Here we review recent developments concerning the applications of nanoparticles, including carbon nanotubes, as synthetic scaffolds for designing nanomedicines. This article will also focus on how understanding and design at the molecular level could help interdisciplinary teams develop research towards new diagnostics and therapeutics both in the short and the long term.
Original languageEnglish
Pages (from-to)3683-3712
Number of pages30
JournalPhilosophical Transactions of the Royal Society A - Mathematical Physical and Engineering Sciences
Volume368
Issue number1924
DOIs
Publication statusPublished - 2010

Fingerprint

Nanomedicine
Biomedical Imaging
Medical nanotechnology
Multimodality
Encapsulation
Nanotubes
Chemistry
Carbon nanotubes
Drugs
Carbon
drugs
Probe
Supramolecular chemistry
carbon nanotubes
Imaging
Imaging techniques
Living Systems
Drug Delivery
Nanomaterials
probes

Cite this

Towards nanomedicines: design protocols to assemble, visualize and test carbon nanotube probes for multi-modality biomedical imaging. / Pascu, Sofia I; Arrowsmith, Rory L; Bayly, S R; Brayshaw, Simon; Hu, Zhiyuan.

In: Philosophical Transactions of the Royal Society A - Mathematical Physical and Engineering Sciences, Vol. 368, No. 1924, 2010, p. 3683-3712.

Research output: Contribution to journalArticle

@article{b186a7ee6b05452297174addae5aec8b,
title = "Towards nanomedicines: design protocols to assemble, visualize and test carbon nanotube probes for multi-modality biomedical imaging",
abstract = "Nanomedicine is an interdisciplinary field, still in its infancy, where an accurate scientific assessment of potential risks and benefits is urgently needed, as is the engagement of end users and the public in this facet of the nanotechnology debate. There is increasing interest in improving our understanding of the interactions between nanomaterials and living systems, with regard to both the underlying chemistry and the physics of effects on the nanoscale. Ultimately, such knowledge promises new vistas for designing the ‘smart’ medicines of the future, of which targeted personalized drugs are the holy grail. Imaging and therapeutic components, including metallic radioisotopes, semiconductor quantum dots and magnetic materials, may be used to construct ‘nanocarriers’ (by encapsulation or conjugation) by rapid and simple (covalent and supramolecular) chemistry. The biomedical functions of the resulting materials are as yet largely unexplored. Encapsulation in nanocarriers could achieve delivery of the reagents (imaging and therapeutic drugs) to the sites of action in the body, while minimizing systemic toxicity and enzymatic degradation. These functional systems have the potential to become a general solution in drug delivery. Here we review recent developments concerning the applications of nanoparticles, including carbon nanotubes, as synthetic scaffolds for designing nanomedicines. This article will also focus on how understanding and design at the molecular level could help interdisciplinary teams develop research towards new diagnostics and therapeutics both in the short and the long term.",
author = "Pascu, {Sofia I} and Arrowsmith, {Rory L} and Bayly, {S R} and Simon Brayshaw and Zhiyuan Hu",
note = "One contribution of 18 to a Triennial Issue ‘Visions of the future for the Royal Society’s 350th anniversary year’.",
year = "2010",
doi = "10.1098/rsta.2010.0081",
language = "English",
volume = "368",
pages = "3683--3712",
journal = "Proceedings of the Royal Society A: Mathematical Physical and Engineering Sciences",
issn = "1364-503X",
publisher = "Royal Society of London",
number = "1924",

}

TY - JOUR

T1 - Towards nanomedicines: design protocols to assemble, visualize and test carbon nanotube probes for multi-modality biomedical imaging

AU - Pascu, Sofia I

AU - Arrowsmith, Rory L

AU - Bayly, S R

AU - Brayshaw, Simon

AU - Hu, Zhiyuan

N1 - One contribution of 18 to a Triennial Issue ‘Visions of the future for the Royal Society’s 350th anniversary year’.

PY - 2010

Y1 - 2010

N2 - Nanomedicine is an interdisciplinary field, still in its infancy, where an accurate scientific assessment of potential risks and benefits is urgently needed, as is the engagement of end users and the public in this facet of the nanotechnology debate. There is increasing interest in improving our understanding of the interactions between nanomaterials and living systems, with regard to both the underlying chemistry and the physics of effects on the nanoscale. Ultimately, such knowledge promises new vistas for designing the ‘smart’ medicines of the future, of which targeted personalized drugs are the holy grail. Imaging and therapeutic components, including metallic radioisotopes, semiconductor quantum dots and magnetic materials, may be used to construct ‘nanocarriers’ (by encapsulation or conjugation) by rapid and simple (covalent and supramolecular) chemistry. The biomedical functions of the resulting materials are as yet largely unexplored. Encapsulation in nanocarriers could achieve delivery of the reagents (imaging and therapeutic drugs) to the sites of action in the body, while minimizing systemic toxicity and enzymatic degradation. These functional systems have the potential to become a general solution in drug delivery. Here we review recent developments concerning the applications of nanoparticles, including carbon nanotubes, as synthetic scaffolds for designing nanomedicines. This article will also focus on how understanding and design at the molecular level could help interdisciplinary teams develop research towards new diagnostics and therapeutics both in the short and the long term.

AB - Nanomedicine is an interdisciplinary field, still in its infancy, where an accurate scientific assessment of potential risks and benefits is urgently needed, as is the engagement of end users and the public in this facet of the nanotechnology debate. There is increasing interest in improving our understanding of the interactions between nanomaterials and living systems, with regard to both the underlying chemistry and the physics of effects on the nanoscale. Ultimately, such knowledge promises new vistas for designing the ‘smart’ medicines of the future, of which targeted personalized drugs are the holy grail. Imaging and therapeutic components, including metallic radioisotopes, semiconductor quantum dots and magnetic materials, may be used to construct ‘nanocarriers’ (by encapsulation or conjugation) by rapid and simple (covalent and supramolecular) chemistry. The biomedical functions of the resulting materials are as yet largely unexplored. Encapsulation in nanocarriers could achieve delivery of the reagents (imaging and therapeutic drugs) to the sites of action in the body, while minimizing systemic toxicity and enzymatic degradation. These functional systems have the potential to become a general solution in drug delivery. Here we review recent developments concerning the applications of nanoparticles, including carbon nanotubes, as synthetic scaffolds for designing nanomedicines. This article will also focus on how understanding and design at the molecular level could help interdisciplinary teams develop research towards new diagnostics and therapeutics both in the short and the long term.

UR - http://www.scopus.com/inward/record.url?scp=77955961152&partnerID=8YFLogxK

UR - http://www.bath.ac.uk/news/2010/07/15/phil-trans-a/

UR - http://dx.doi.org/10.1098/rsta.2010.0081

U2 - 10.1098/rsta.2010.0081

DO - 10.1098/rsta.2010.0081

M3 - Article

VL - 368

SP - 3683

EP - 3712

JO - Proceedings of the Royal Society A: Mathematical Physical and Engineering Sciences

JF - Proceedings of the Royal Society A: Mathematical Physical and Engineering Sciences

SN - 1364-503X

IS - 1924

ER -